Internal Medicine

Partner With Us

Advertisement

From the Journals FDA & Government News

NEJM Retracts Avacopan Vasculitis Study

"The primary end-point assessments in nine patients were readjudicated after database lock and trial unblinding"

Edited Kathryn Wighton

Conexiant July 1, 2026

Content Currently Unavailable

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.